Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus
Conditions
Interventions
Baseline examinations were performed November 2009 - November 2016. To ensure quality of the data collected, standard operation procedures were developed and used in all 8 recruitment centers. From al
Sponsors
VU Universtity Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with type 2 diabetes mellitus according to WHO criteria 2. Treated by a Dutch University Clinic, an associated primary care clinic or transmural care system
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diabetes complications and mortality: 1. Cardio-metabolic risk factors, assessed by anthropometry, blood pressure, ECG, ankle-brachial index, laboratory measurements, and self-report questionnaire at baseline 2. Retinopathy, assessed by retinal photography at baseline 3. Nephropathy, assessed with laboratory measurements at baseline 4. Neuropathy, assessed by peripheral vibration perception at baseline Follow-up visits have not been planned yet. Follow-up of morbidity and mortality is done through medical care providers and municipal registries. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life and physical functioning, assessed by self-reported questionnaire at baseline | — |
Countries
Netherlands
Outcome results
None listed